UBS Group’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
3,996
+1,090
| +38% | +$27.9K | ﹤0.01% | 5963 |
|
|
2025
Q1 | $79.9K | Buy |
2,906
+1,402
| +93% | +$38.5K | ﹤0.01% | 5945 |
|
|
2024
Q4 | $40.6K | Buy |
+1,504
| New | +$40.6K | ﹤0.01% | 6209 |
|
|
2024
Q3 | – | Sell |
-29
| Closed | -$790 | – | 8428 |
|
|
2024
Q2 | $790 | Buy |
+29
| New | +$790 | ﹤0.01% | 7608 |
|
|
2024
Q1 | – | Sell |
-1,744
| Closed | -$46.4K | – | 8289 |
|
|
2023
Q4 | $46.4K | Buy |
+1,744
| New | +$46.4K | ﹤0.01% | 5375 |
|
|
2023
Q3 | – | Sell |
-4,261
| Closed | -$112K | – | 8428 |
|
|
2023
Q2 | $112K | Buy |
4,261
+2,500
| +142% | +$65.5K | ﹤0.01% | 4870 |
|
|
2023
Q1 | $46K | Sell |
1,761
-317
| -15% | -$8.27K | ﹤0.01% | 5436 |
|
|
2022
Q4 | $57K | Buy |
2,078
+1,651
| +387% | +$45.3K | ﹤0.01% | 5500 |
|
|
2022
Q3 | $10K | Buy |
+427
| New | +$10K | ﹤0.01% | 7317 |
|
|
2022
Q2 | – | Sell |
-828
| Closed | -$22K | – | 9408 |
|
|
2022
Q1 | $22K | Buy |
828
+464
| +127% | +$12.3K | ﹤0.01% | 6299 |
|
|
2021
Q4 | $10K | Sell |
364
-594
| -62% | -$16.3K | ﹤0.01% | 7649 |
|
|
2021
Q3 | $25K | Buy |
958
+67
| +8% | +$1.75K | ﹤0.01% | 5785 |
|
|
2021
Q2 | $23K | Sell |
891
-1,373
| -61% | -$35.4K | ﹤0.01% | 6094 |
|
|
2021
Q1 | $58K | Buy |
2,264
+2,253
| +20,482% | +$57.7K | ﹤0.01% | 5397 |
|
|
2020
Q4 | $0 | Buy |
+11
| New | – | ﹤0.01% | 7440 |
|
|
2020
Q1 | – | Sell |
-1,506
| Closed | -$35K | – | 7072 |
|
|
2019
Q4 | $35K | Sell |
1,506
-353
| -19% | -$8.2K | ﹤0.01% | 5503 |
|
|
2019
Q3 | $38K | Buy |
1,859
+265
| +17% | +$5.42K | ﹤0.01% | 5395 |
|
|
2019
Q2 | $34K | Buy |
1,594
+92
| +6% | +$1.96K | ﹤0.01% | 5367 |
|
|
2019
Q1 | $32K | Buy |
+1,502
| New | +$32K | ﹤0.01% | 5070 |
|
|
2018
Q3 | – | Sell |
-266
| Closed | -$6K | – | 7072 |
|
|
2018
Q2 | $6K | Buy |
+266
| New | +$6K | ﹤0.01% | 6476 |
|
|
2018
Q1 | – | Sell |
-784
| Closed | -$17K | – | 6946 |
|
|
2017
Q4 | $17K | Buy |
+784
| New | +$17K | ﹤0.01% | 5703 |
|
|
2017
Q3 | – | Sell |
-1,234
| Closed | -$26K | – | 6811 |
|
|
2017
Q2 | $26K | Sell |
1,234
-66
| -5% | -$1.39K | ﹤0.01% | 5170 |
|
|
2017
Q1 | $26K | Buy |
+1,300
| New | +$26K | ﹤0.01% | 5048 |
|